← Back to Search

Remote Temperature Monitoring for Diabetic Foot Care (STOP Trial)

N/A
Recruiting
Led By Alyson J. Littman, PhD MPH
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Veteran with diabetes diagnosis
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6,12, 18 and 24 months
Awards & highlights

STOP Trial Summary

This trial aims to test a "smart" mat that can reduce the risk of diabetic foot ulcer recurrence. It will also evaluate how well it is accepted and used in the VA.

Who is the study for?
This trial is for Veterans with diabetes who can read English and have had either a lower extremity amputation or foot ulcer in the past 24 months. It's not for those with dementia, prisoners, current users of in-home temperature monitoring, non-ambulatory individuals, or those with severe peripheral arterial disease.Check my eligibility
What is being tested?
The study tests if a 'smart' mat that monitors foot temperature and sends data to a remote team helps prevent ulcers compared to usual care. The goal is to see if this tech makes it easier and more effective for patients to monitor their condition.See study design
What are the potential side effects?
Since this trial involves remote monitoring rather than medication or invasive procedures, there are no direct side effects from the intervention itself.

STOP Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a veteran diagnosed with diabetes.

STOP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6,12, 18 and 24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6,12, 18 and 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Rate of foot ulceration
Secondary outcome measures
Mean or median quality of life scores
Mean or median satisfaction with care scores
Mean or median self-efficacy for diabetes
+1 more
Other outcome measures
Utilization (outpatient visits, emergency room visits, hospitalizations) - any vs. none and number

STOP Trial Design

2Treatment groups
Experimental Treatment
Group I: Remote temperature monitoring + enhanced usual careExperimental Treatment2 Interventions
Enrollment in remote foot temperature monitoring in addition to enhanced usual care (described below)
Group II: Enhanced usual careExperimental Treatment1 Intervention
Usual care is based on the VA's amputation prevention program (PAVE - Preventing Amputation in Veterans Everywhere - VHA Directive 1410), which provides a model of care for patients at risk for amputation as well as patients who have already undergone an amputation. Usual care will be enhanced by providing resources (e.g., information through written newsletters) relevant to a population of Veterans with diabetes, including information on nutrition and cooking, physical activities, and Whole Health opportunities

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,611 Previous Clinical Trials
3,304,484 Total Patients Enrolled
5 Trials studying Diabetic Foot
530 Patients Enrolled for Diabetic Foot
Alyson J. Littman, PhD MPHPrincipal InvestigatorVA Puget Sound Health Care System Seattle Division, Seattle, WA
3 Previous Clinical Trials
4,888 Total Patients Enrolled

Media Library

Remote foot temperature monitoring system Clinical Trial Eligibility Overview. Trial Name: NCT05728411 — N/A
Diabetic Foot Research Study Groups: Enhanced usual care, Remote temperature monitoring + enhanced usual care
Diabetic Foot Clinical Trial 2023: Remote foot temperature monitoring system Highlights & Side Effects. Trial Name: NCT05728411 — N/A
Remote foot temperature monitoring system 2023 Treatment Timeline for Medical Study. Trial Name: NCT05728411 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

May I be part of this experiment?

"Aspiring participants to this trial must have diabetic foot and be aged between 18-89. In total, about 800 individuals are sought for the clinical trial."

Answered by AI

Does this clinical trial invite elderly patients to participate?

"This clinical trial has an age limit of 18-89, though there are 4 trials for minors and 123 studies specifically targeting elderly populations."

Answered by AI

Are there any further openings available in this medical experiment?

"The details of this clinical trial, which was published on March 20th 2022 and last amended on February 3rd 2023 reveal that the study is no longer recruiting participants. Nevertheless, there are 125 other trials actively accepting candidates at present."

Answered by AI
~533 spots leftby Dec 2026